Trial Management Group

Trial Closure

MA.27B, The Influence of Five Years of Adjuvant Anastrozole or Exemestane on Bone Mineral Density in Postmenopausal Women with Primary Breast Cancer - A Companion Study to MA.27, is officially closed to accrual as of May 30, 2008. http://www.ctg.queensu.ca/trials/breast/ma27b/ma27b.html